LMO2 Is a Novel Predictive Marker for a Better Prognosis in Pancreatic Cancer

PURPOSE: LIM domain only 2 (LMO2) has been identified as a novel oncogene associated with carcinogenesis and better prognosis in several malignant tumors. We investigate the involvement of LMO2 in pancreatic cancer. EXPERIMENTAL DESIGN: We evaluated LMO2 expression in cultured cells, bulk tissues, a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Nakata, Kohei, Ohuchida, Kenoki, Nagai, Eishi, Hayashi, Akifumi, Miyasaka, Yoshihiro, Kayashima, Tadashi, Yu, Jun, Aishima, Shinichi, Oda, Yoshinao, Mizumoto, Kazuhiro, Tanaka, Masao, Tsuneyoshi, Masazumi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Neoplasia Press Inc. 2009
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697357/
https://ncbi.nlm.nih.gov/pubmed/19568416
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items